Example: Heart Attack

Search clinical trials for: Antineoplastic Agents, Alkylating

Total 5340 results

    • NCT02678975
      Completed
      Disulfiram in Recurrent Glioblastoma
      Conditions: Glioma; Glioblastoma
    • NCT03045471
      Not yet recruiting
      The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
      Conditions: To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
    • NCT03159143
      Completed
      Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract
      Conditions: Metastatic Transitional Cell Cancer of the Urothelial Tract
    • NCT03538899
      Recruiting
      Autologous Gene Therapy for Artemis-Deficient SCID
      Conditions: Severe Combined Immunodeficiency
    • NCT01860040
      Terminated
      Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
      Conditions: Non-squamous Cell Non-Metastatic Non-Small Cell Lung Cancer; Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer
    • NCT00050427
      Completed
      A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer
      Conditions: Breast Neoplasms; Neoplasms; Neoplasms by Site; Breast Diseases; Skin Diseases
    • NCT02855359
      Terminated
      Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
      Conditions: Diffuse, Large B-Cell, Lymphoma; Follicular Lymphoma, Grade 3b; Transformed Lymphoma / DLBCL
    • NCT03349450
      Active, not recruiting
      DPX-Survivac and Checkpoint Inhibitor in DLBCL
      Conditions: Adult Diffuse Large Cell Lymphoma; Recurrent; Adult Refractory Diffuse Large B-Cell Lymphoma
    • NCT02806375
      Completed
      PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
      Conditions: Primary Myelofibrosis; Myeloproliferative Disorders
    • NCT02627573
      Terminated
      Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT
      Conditions: Leukemia, Chronic Myeloid; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
    • NCT02799147
      Completed
      GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
      Conditions: Leukemia, Acute Lymphoblastic; Acute Myeloid Leukemia; Mixed-Lineage Acute Leukemias
    • NCT00365274
      Terminated
      SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
      Conditions: Anaplastic Large Cell Lymphoma
    • NCT02294552
      Completed
      Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
      Conditions: Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Lymphoma; Myelodysplastic Syndromes; Chronic Lymphocytic Leukemia; Immune System Diseases
    • NCT00050414
      Completed
      A Study of Trabectedin in Patients With Advanced Ovarian Cancer
      Conditions: Ovarian Neoplasms; Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Ovarian Diseases; Adnexal Diseases; Genital Diseases, Female
    • NCT00000899
      Completed
      A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients
      Conditions: HIV Infections
    • NCT04430036
      Recruiting
      AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
      Conditions: Urinary Bladder Neoplasms
    • NCT04310592
      Recruiting
      Natural Killer Cell (CYNK-001) Infusions in Adults With AML
      Conditions: Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms by Histologic Type; Neoplasms; Immunosuppressive Agents; Immunologic Factors; Physiological Effects of Drugs; Alkylating Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Analgesics, Non-narcotic; Anti-infective Agents; Analgesics; Peripheral Nervous System Agents; Hematologic Diseases; Hematologic Neoplasms; Leukemia in Remission
    • NCT01204801
      Unknown status
      Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
      Conditions: Breast Cancer
    • NCT03466450
      Recruiting
      Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
      Conditions: Glioblastoma
    • NCT04762069
      Not yet recruiting
      A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
      Conditions: Glioblastoma Multiforme, Adult
    • NCT04552977
      Not yet recruiting
      A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
      Conditions: Glioblastoma
    • NCT04625907
      Recruiting
      FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
      Conditions: Rhabdomyosarcoma
    • NCT01520922
      Completed
      Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
      Conditions: Chronic Lymphocytic Leukemia (CLL); Leukaemia, Lymphocytic, Chronic
    • NCT00168922
      Unknown status
      Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
      Conditions: Recurrent Small Cell Lung Cancer
    • NCT00695032
      Suspended
      Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
      Conditions: Chemotherapeutic Agent Toxicity; Renal Toxicity; Unspecified Adult Solid Tumor, Protocol Specific
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations